HNGE insider files Form 144 to sell 14,763 RSUs

James Budge reported a proposed sale of 14,763 restricted stock units of HNGE via Form 144.

Rhea-AI Filing Summary

James Budge reported a proposed sale of 14,763 restricted stock units of HNGE via Form 144. The filing lists prior 10b5-1 sales of Common stock: 10,491 shares on 12/22/2025 for $507,836.79 and 44,589 shares on 11/25/2025 for $2,116,778.06. The securities to be sold are described as Restricted Stock Units with an effective date of 01/01/2026.

Insights

Corporate Governance Analyst

Routine insider resale notice showing scheduled RSU sale and recent 10b5-1 activity.

The filing lists a proposed sale of 14,763 restricted stock units dated 01/01/2026

Recent activity includes two 10b5-1 executed sales: 10,491 shares on 12/22/2025 for $507,836.79 and 44,589 shares on 11/25/2025 for $2,116,778.06.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does James Budge's Form 144 for HNGE report?

It reports a proposed sale of 14,763 restricted stock units of HNGE with an effective date of 01/01/2026. The filing also lists prior 10b5-1 sales executed in 2025.

How many shares did James Budge sell in November and December 2025?

The filing shows 44,589 shares sold on 11/25/2025 and 10,491 shares sold on 12/22/2025, executed under 10b5-1 plans.

What proceeds were reported for the prior 10b5-1 sales?

Proceeds shown are $2,116,778.06 for the 11/25/2025 sale and $507,836.79 for the 12/22/2025 sale, as listed in the filing.

Who is the broker or intermediary listed on the Form 144?

The filing lists Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza as the broker/intermediary in the filing information.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/23/2026 - 04:30 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001338176
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	455 Market Street, Suite 700 San Francisco CALIFORNIA 94105
Phone	4157262206
Name of Person for Whose Account the Securities are To Be Sold	JAMES BUDGE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	14763	609859.53	37919155	02/23/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/01/2026	Restricted Stock Units	Issuer			14763	01/01/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JAMES BUDGE 455 Market Street, Suite 700 San Francisco CA 94105	Common	12/22/2025	10491	507836.79
10b5-1 Sales for JAMES BUDGE 455 Market Street, Suite 700 San Francisco CA 94105	Common	11/25/2025	44589	2116778.06

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 1/1/2026 through 2/1/2026
Date of Notice	02/23/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/07/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ James Budge
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)